Pazopanib in Kidney Cancer vs Sarcoma: — Two Different Treatment Goals

In both kidney cancer and sarcoma, pazopanib is intended to control the disease rather than remove it. In advanced kidney cancer, prolonged control is a realistic and meaningful aim, and some patients remain on treatment for an extended period. In sarcoma, the goal is to slow progression after chemotherapy has stopped working. What your own situation can achieve is a question for your oncologist, who knows how far the disease has spread and how it has behaved so far.

Most foods are fine, but the timing of the tablet relative to food matters. Pazopanib must be taken on an empty stomach because food — particularly high-fat food — significantly increases the amount the body absorbs and raises the risk of side effects unpredictably. Take it at the same time each day, at least one hour before you eat or two hours after. Grapefruit and grapefruit juice interact with many targeted therapies and are best avoided unless your team says otherwise.

The most common are raised blood pressure, diarrhoea, fatigue, and nausea. Hair colour change — hair becoming lighter or white — is well recognised and harmless. Hand-foot syndrome, where the palms and soles become sore and red, affects some patients. Liver enzyme levels rise in a number of patients, which is why blood tests continue throughout treatment. Most side effects are manageable when they are reported early, so tell your team about anything new rather than waiting for your next scheduled appointment.

Your team monitors liver function regularly because pazopanib can raise liver enzymes. If levels rise, your team may reduce the dose or pause treatment to let the liver recover, then restart at a lower dose. In most cases this is manageable when caught on routine testing — which is why missing blood test appointments matters. Rarely, if the liver is significantly affected, treatment may need to stop. Report any yellowing of the skin or eyes between scheduled tests immediately.

Not necessarily without review. Pazopanib interacts with a number of commonly used medicines, including some blood pressure tablets, cholesterol medicines, antifungals, and antibiotics, because of the way it is processed in the liver. Supplements and herbal medicines — including many Ayurvedic preparations — can also interact. Give your oncology team a complete list of everything you take before you start, and tell them before adding or stopping anything during treatment.

Your team will schedule imaging — usually CT scans — at regular intervals to compare tumour size and spread over time. Stability, meaning the disease has not grown, counts as a meaningful response to treatment in both settings, not only shrinkage. Day-to-day symptoms are not a reliable guide to whether the drug is working — some patients feel well on a treatment that is not controlling the disease, and some feel unwell on one that is. Imaging is what tells the real story.